Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
- PMID: 18615077
- PMCID: PMC2700032
- DOI: 10.1038/nature07082
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Abstract
Ebola virus (EBOV) entry requires the surface glycoprotein (GP) to initiate attachment and fusion of viral and host membranes. Here we report the crystal structure of EBOV GP in its trimeric, pre-fusion conformation (GP1+GP2) bound to a neutralizing antibody, KZ52, derived from a human survivor of the 1995 Kikwit outbreak. Three GP1 viral attachment subunits assemble to form a chalice, cradled by the GP2 fusion subunits, while a novel glycan cap and projected mucin-like domain restrict access to the conserved receptor-binding site sequestered in the chalice bowl. The glycocalyx surrounding GP is likely central to immune evasion and may explain why survivors have insignificant neutralizing antibody titres. KZ52 recognizes a protein epitope at the chalice base where it clamps several regions of the pre-fusion GP2 to the amino terminus of GP1. This structure provides a template for unravelling the mechanism of EBOV GP-mediated fusion and for future immunotherapeutic development.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2700032/bin/nihms-78901-f0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2700032/bin/nihms-78901-f0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2700032/bin/nihms-78901-f0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2700032/bin/nihms-78901-f0004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2700032/bin/nihms-78901-f0005.gif)
Similar articles
-
The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development.Viruses. 2019 Oct 31;11(11):999. doi: 10.3390/v11110999. Viruses. 2019. PMID: 31683550 Free PMC article. Review.
-
The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.J Virol. 2016 Nov 28;90(24):11075-11086. doi: 10.1128/JVI.01563-16. Print 2016 Dec 15. J Virol. 2016. PMID: 27707924 Free PMC article.
-
[Research progress on ebola virus glycoprotein].Bing Du Xue Bao. 2013 Mar;29(2):233-7. Bing Du Xue Bao. 2013. PMID: 23757858 Review. Chinese.
-
Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S825-32. doi: 10.1093/infdis/jir295. J Infect Dis. 2011. PMID: 21987758 Free PMC article.
-
Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein.Acta Crystallogr D Biol Crystallogr. 2009 Nov;65(Pt 11):1162-80. doi: 10.1107/S0907444909032314. Epub 2009 Oct 22. Acta Crystallogr D Biol Crystallogr. 2009. PMID: 19923712 Free PMC article.
Cited by
-
Molecular insights into the Ebola virus life cycle.Nat Microbiol. 2024 Jun;9(6):1417-1426. doi: 10.1038/s41564-024-01703-z. Epub 2024 May 23. Nat Microbiol. 2024. PMID: 38783022 Review.
-
Ebola Virus Glycoprotein Strongly Binds to Membranes in the Absence of Receptor Engagement.ACS Infect Dis. 2024 May 10;10(5):1590-1601. doi: 10.1021/acsinfecdis.3c00622. Epub 2024 Apr 29. ACS Infect Dis. 2024. PMID: 38684073 Free PMC article.
-
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.PLoS Pathog. 2024 Apr 11;20(4):e1012134. doi: 10.1371/journal.ppat.1012134. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38603762 Free PMC article.
-
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.NPJ Vaccines. 2024 Mar 29;9(1):67. doi: 10.1038/s41541-024-00833-z. NPJ Vaccines. 2024. PMID: 38553525 Free PMC article.
-
Cancer cells and viruses share common glycoepitopes: exciting opportunities toward combined treatments.Front Immunol. 2024 Mar 1;15:1292588. doi: 10.3389/fimmu.2024.1292588. eCollection 2024. Front Immunol. 2024. PMID: 38495885 Free PMC article. Review.
References
-
- Sanchez A, et al. In: Fields Virology. Knipe DM, Howley PM, editors. Lippincott, Williams, and Wilkins; Philadelphia: 2001. pp. 1279–1304.
-
- Johnson KM, Lange JV, Webb PA, Murphy FA. Isolation and characterization of a new virus causing acute hemorrhagic fever in Zaire. Lancet. 1977;1:569–571. - PubMed
-
- Alsop Z. Ebola outbreak in Uganda “atypical”, say experts. Lancet. 2007;370:2085. - PubMed
-
- World Health Organization . Ebola haemorrhagic fever in Uganda. 2007.
-
- Peters CJ, Sanchez A, Rollin PE, Ksiazek TG, Murphy GA. In: Fields Virology. Fields BN, Knipe DM, Howley PM, editors. Vol. 1. Lippincott-Raven Press, Inc.; Philadelphia, PA: 1996. pp. 1161–1176.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous